Here are five facts:
1. Royal Bank of Canada has an “outperform” rating on AmSurg shares.
2. The firm’s price objective indicates a 32.58 percent potential upside compared to AmSurg’s previous close.
3. On Jan. 5, AmSurg opened the day trading at $65.62.
4. The company’s 50-day moving average is $54.74 and a 200-day moving average is $30.30.
5. AmSurg’s market cap totals $3.53 billion.
More articles on surgery centers:
From total knees to hip arthoplasties: How Premier Orthopedic Surgery Center is tackling the evolving outpatient landscape
4 recent ASC acquisitions — Jan. 5, 2016
Envision Healthcare Corp. acquires Sunshine Radiology — 4 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
